1.Alternative Name:FOLR-1,FOLR
2.Target:FOLR1
3.Source:Human FOLR1 was expressed from HEK293 with human IgG1 FC at the C-terminal
4.Sequence:Arg25-Met233
5.Protein structure::P15328hFC
6.Molecular Characterization:The protein has a calculated MW of 50kDa.The reducing (R) heterodimer protein migrates as 55-70 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 95%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 95%.

13.ELISA

When Recombinant Human FOLR1/hFC Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human FOLR1 (Farletuzumab) that produces 50% of the optimal binding response is approximately 100 ng/ml.

14.Note：For research use only .